FRED HUTCHINSON CANCER CENTER
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer
Dissecting the immunomodulatory effects of NK cells on immune responses to cancer is a funding opportunity from FRED HUTCHINSON CANCER CENTER, up to 563228, closing August 31, 2029.
Aug 31, 2029
(1127d left)Overview
PROJECT SUMMARY Current immunotherapies, such as anti-PD-1 immunotherapy, have low objective responses in patients, necessitating the development of novel therapies that boost immune responses to cancer and responses to these treatments. Further, most immunotherapies in the clinic, anti-PD-1 immunotherapy included,…